Carol G. Gallagher's Insider Trades & SAST Disclosures
Carol G. Gallagher's most recent trade in PMV Pharmaceuticals Inc was a trade of 67,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 6, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Carol G. Gallagher.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| PMV Pharmaceuticals Inc | Carol G. Gallagher | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jun 2024 | 67,500 | 67,500 | - | - | Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Carol G. Gallagher | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jun 2024 | 67,500 | 0 | - | - | Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Carol G. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 67,500 | 67,500 | - | - | Stock Option (right to buy) | |
| Atara Biotherapeutics Inc | Carol G. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2024 | 150,000 | 629,608 (1%) | 0% | 0 | Common Stock | |
| Mirati Therapeutics Inc | Carol G. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 12,784 | 12,784 | - | - | Employee Stock Option (Right to Buy) | |
| Mirati Therapeutics Inc | Carol G. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 7,555 | 7,555 (0%) | 0% | 0 | Common Stock | |
| PMV Pharmaceuticals Inc | Carol G. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 21,500 | 21,500 | - | - | Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Carol G. Gallagher | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Jun 2023 | 21,500 | 21,500 | - | - | Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Carol G. Gallagher | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Jun 2023 | 21,500 | 0 | - | - | Stock Option (right to buy) | |
| Atara Biotherapeutics Inc | Carol G. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 79,500 | 79,500 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Carol G. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 57,000 | 189,418 (0%) | 0% | 0 | Common Stock | |
| PMV Pharmaceuticals Inc | Carol G. Gallagher | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Nov 2022 | 39,000 | 39,000 | - | - | Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Carol G. Gallagher | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Nov 2022 | 39,000 | 39,000 | - | - | Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Carol G. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2022 | 39,000 | 39,000 | - | - | Stock Option (right to buy) | |
| Atara Biotherapeutics Inc | Carol G. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 31,500 | 31,500 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Carol G. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 20,500 | 132,418 (0%) | 0% | 0 | Common Stock | |
| Certara Inc | Carol G. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 7,059 | 7,059 | - | 0 | Common Stock | |
| Atara Biotherapeutics Inc | Carol G. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 17,500 | 17,500 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Carol G. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 11,000 | 111,818 (0%) | 0% | 0 | Common Stock | |
| Atara Biotherapeutics Inc | Carol G. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 24,500 | 24,500 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Carol G. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 8,000 | 100,818 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges